NewsBenzingaStephens & Co. Mantiene la Recomendación de Igual Peso sobre Ovintiv y Eleva el Precio Objetivo a $77 Stephens & Co. Mantiene la Recomendación de Igual Peso sobre Ovintiv y Eleva el Precio Objetivo a $77 Benzinga 2026.10.27 17:13 (GMT+0) Open on Benzinga Other news Xylem Stock Plunges to 52-Week Low After Slashing 2026 Profit Outlook Ecolab Q3 2026 Earnings Call Transcript Ouster Stock Surges After Stereolabs Unveils ZED Box 2 Bitcoin Reclaims $80,000 as ETH, XRP, DOGE Hold Steady Ahead of FOMC Wednesday Vanda Pharmaceuticals Targets Major GLP-1 Market Challenge with Positive Trial Outcomes Why Is Intuitive Machines Stock Surging on Tuesday?
